Skip to content

Ayurvedic management of metabolic syndrome with life style modification.

Role of lifestyle modification intervention and Triphala Kajjali tablet in the management of metabolic syndrome - A single blind randomized comparative clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025391
Enrollment
70
Registered
2020-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: -

Interventions

Intervention1: Placebo tablet: Group-A Patients will be advised to follow lifestyle modification intervention as per their Prakriti and status of Agni along with Placebo capsule. Control Intervention

Sponsors

IPGT AND RA Gujrat ayurved University Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having age between 20 ââ?¬â?? 50 years of either sex 2.Abdominal obesity, (waist circumference >102 cm in men and >88 cm in women) 3.Hypertriglyceridemia (S. Triglycerides level 150-300 mg/dl) 4.Low HDL cholesterol (S.HDL cholesterol 5.Elevated blood pressure (Systolic blood pressure above 130mmHg and/or diastolic blood pressure above 85mmHg) 6.Impaired fasting glucose (Fasting plasma glucose 100-125 mg/dl).

Exclusion criteria

Exclusion criteria: 1.Age below 20 and above 50 years. 2.Drug-induced dyslipidemia. 3.Systemic illness like Tuberculosis, Carcinoma and Endocrine disorders like Cushing syndrome, Hypothyroidism. 4.Patient having the past history of M.I. & Unstable Angina. 5.Patient having Clinical Features of CCF. 6.Patients having a major renal or liver disorder. 7.Patients having fasting blood sugar � 150 mg/dl. 8.Patients taking allopathic treatment of Diabetes, Hypertension or Cholesterol.

Design outcomes

Primary

MeasureTime frame
Changes in sign and symptoms as per gradationTimepoint: Graded score of sign and symptoms prepared by investigator 1.Weekly assessment for 12 weeks;for changes in sign and symptoms 2.full assesement after completion of treatment (after 12 weeks) 3.follow up will be done for four weeks after completion of treatment.

Secondary

MeasureTime frame
Improvement in sign and symptoms as per gradationTimepoint: Improvement in sign and symptoms as per gradation within 12 weeks

Countries

India

Contacts

Public ContactDr Jaynika Garasia

Institute for Post Graduate Teaching and Research in Ayurveda, Jamnagar

mandipgoyal22@gmail.com9427572306

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026